Does COVID-19 cause an increased risk of hospitalization or death in patients with inflammatory rheumatic diseases treated with biological DMARDs or targeted synthetic DMARDs?

Detalles Bibliográficos
Autores principales: Lwin, May, Holroyd, Christopher, Wallis, Dinny, Davidson, Brian, Goulston, Lyndsey, de Graaf, Hans, Edwards, Christopher J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Letter to the Editor (Other)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7661840/
https://www.ncbi.nlm.nih.gov/pubmed/33210076
http://dx.doi.org/10.1093/rap/rkaa061

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7661840/
https://www.ncbi.nlm.nih.gov/pubmed/33210076
http://dx.doi.org/10.1093/rap/rkaa061

Ejemplares similares